AustralieFrV1, Main, Exploration, bibRecord, 001D52

How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.

Identifieur interne : 001D52 ( Main/Exploration ); précédent : 001D51; suivant : 001D53

How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.

Auteurs : Josep M. Borras [Espagne] ; Yolande Lievens [Belgique] ; Michael Barton [Australie] ; Julieta Corral [Espagne] ; Jacques Ferlay [France] ; Freddie Bray [France] ; Cai Grau [Danemark]

Source :

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [ 1879-0887 ] ; 2016.

RBID : pubmed:26922487

Descripteurs français

KwdFr :
- Australie, Bases de données factuelles (), Europe (épidémiologie), Femelle, Humains, Incidence, Mâle, Prévision, Tumeurs (radiothérapie), Tumeurs (épidémiologie).
MESH :
- radiothérapie : Tumeurs.
- épidémiologie : Europe, Tumeurs.
- Australie, Bases de données factuelles, Femelle, Humains, Incidence, Mâle, Prévision.

English descriptors

KwdEn :
- Australia, Databases, Factual (statistics & numerical data), Europe (epidemiology), Female, Forecasting, Humans, Incidence, Male, Neoplasms (epidemiology), Neoplasms (radiotherapy).
MESH :
- epidemiology : Europe, Neoplasms.
- radiotherapy : Neoplasms.
- statistics & numerical data : Databases, Factual.
- Australia, Female, Forecasting, Humans, Incidence, Male.

Abstract

The objective of this HERO study was to assess the number of new cancer patients that will require at least one course of radiotherapy by 2025.

DOI: 10.1016/j.radonc.2016.02.016
PubMed: 26922487

Affiliations:

Australie, Belgique, Danemark, Espagne, France
Auvergne-Rhône-Alpes, Catalogne, Rhône-Alpes
Barcelone, Lyon

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.</title>
<author><name sortKey="Borras, Josep M" sort="Borras, Josep M" uniqKey="Borras J" first="Josep M" last="Borras">Josep M. Borras</name>
<affiliation wicri:level="3"><nlm:affiliation>University of Barcelona, IDIBELL, Barcelona, Spain. Electronic address: jmborras@ub.edu.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>University of Barcelona, IDIBELL, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lievens, Yolande" sort="Lievens, Yolande" uniqKey="Lievens Y" first="Yolande" last="Lievens">Yolande Lievens</name>
<affiliation wicri:level="1"><nlm:affiliation>Radiation Oncology Department, Ghent University Hospital, Ghent, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Radiation Oncology Department, Ghent University Hospital, Ghent</wicri:regionArea>
<wicri:noRegion>Ghent</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Barton, Michael" sort="Barton, Michael" uniqKey="Barton M" first="Michael" last="Barton">Michael Barton</name>
<affiliation wicri:level="1"><nlm:affiliation>CCORE Ingham Institute for Applied Medical Research, University of South New Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>CCORE Ingham Institute for Applied Medical Research, University of South New Wales</wicri:regionArea>
<wicri:noRegion>University of South New Wales</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Corral, Julieta" sort="Corral, Julieta" uniqKey="Corral J" first="Julieta" last="Corral">Julieta Corral</name>
<affiliation wicri:level="3"><nlm:affiliation>Catalan Cancer Strategy, Department of Health, Generalitat de Catalunya, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Catalan Cancer Strategy, Department of Health, Generalitat de Catalunya, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ferlay, Jacques" sort="Ferlay, Jacques" uniqKey="Ferlay J" first="Jacques" last="Ferlay">Jacques Ferlay</name>
<affiliation wicri:level="3"><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bray, Freddie" sort="Bray, Freddie" uniqKey="Bray F" first="Freddie" last="Bray">Freddie Bray</name>
<affiliation wicri:level="3"><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Grau, Cai" sort="Grau, Cai" uniqKey="Grau C" first="Cai" last="Grau">Cai Grau</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Oncology, Aarhus University Hospital, Aarhus</wicri:regionArea>
<wicri:noRegion>Aarhus</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26922487</idno>
<idno type="pmid">26922487</idno>
<idno type="doi">10.1016/j.radonc.2016.02.016</idno>
<idno type="wicri:Area/PubMed/Corpus">002054</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002054</idno>
<idno type="wicri:Area/PubMed/Curation">002029</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002029</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002029</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002029</idno>
<idno type="wicri:Area/Ncbi/Merge">003204</idno>
<idno type="wicri:Area/Ncbi/Curation">003204</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003204</idno>
<idno type="wicri:Area/Main/Merge">001D49</idno>
<idno type="wicri:Area/Main/Curation">001D52</idno>
<idno type="wicri:Area/Main/Exploration">001D52</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.</title>
<author><name sortKey="Borras, Josep M" sort="Borras, Josep M" uniqKey="Borras J" first="Josep M" last="Borras">Josep M. Borras</name>
<affiliation wicri:level="3"><nlm:affiliation>University of Barcelona, IDIBELL, Barcelona, Spain. Electronic address: jmborras@ub.edu.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>University of Barcelona, IDIBELL, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lievens, Yolande" sort="Lievens, Yolande" uniqKey="Lievens Y" first="Yolande" last="Lievens">Yolande Lievens</name>
<affiliation wicri:level="1"><nlm:affiliation>Radiation Oncology Department, Ghent University Hospital, Ghent, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Radiation Oncology Department, Ghent University Hospital, Ghent</wicri:regionArea>
<wicri:noRegion>Ghent</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Barton, Michael" sort="Barton, Michael" uniqKey="Barton M" first="Michael" last="Barton">Michael Barton</name>
<affiliation wicri:level="1"><nlm:affiliation>CCORE Ingham Institute for Applied Medical Research, University of South New Wales, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>CCORE Ingham Institute for Applied Medical Research, University of South New Wales</wicri:regionArea>
<wicri:noRegion>University of South New Wales</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Corral, Julieta" sort="Corral, Julieta" uniqKey="Corral J" first="Julieta" last="Corral">Julieta Corral</name>
<affiliation wicri:level="3"><nlm:affiliation>Catalan Cancer Strategy, Department of Health, Generalitat de Catalunya, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Catalan Cancer Strategy, Department of Health, Generalitat de Catalunya, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ferlay, Jacques" sort="Ferlay, Jacques" uniqKey="Ferlay J" first="Jacques" last="Ferlay">Jacques Ferlay</name>
<affiliation wicri:level="3"><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bray, Freddie" sort="Bray, Freddie" uniqKey="Bray F" first="Freddie" last="Bray">Freddie Bray</name>
<affiliation wicri:level="3"><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Grau, Cai" sort="Grau, Cai" uniqKey="Grau C" first="Cai" last="Grau">Cai Grau</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Oncology, Aarhus University Hospital, Aarhus</wicri:regionArea>
<wicri:noRegion>Aarhus</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</title>
<idno type="eISSN">1879-0887</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Australia</term>
<term>Databases, Factual (statistics & numerical data)</term>
<term>Europe (epidemiology)</term>
<term>Female</term>
<term>Forecasting</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Neoplasms (epidemiology)</term>
<term>Neoplasms (radiotherapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Australie</term>
<term>Bases de données factuelles ()</term>
<term>Europe (épidémiologie)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Mâle</term>
<term>Prévision</term>
<term>Tumeurs (radiothérapie)</term>
<term>Tumeurs (épidémiologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Europe</term>
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Databases, Factual</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Europe</term>
<term>Tumeurs</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Australia</term>
<term>Female</term>
<term>Forecasting</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Australie</term>
<term>Bases de données factuelles</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Mâle</term>
<term>Prévision</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The objective of this HERO study was to assess the number of new cancer patients that will require at least one course of radiotherapy by 2025.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
<li>Belgique</li>
<li>Danemark</li>
<li>Espagne</li>
<li>France</li>
</country>
<region><li>Auvergne-Rhône-Alpes</li>
<li>Catalogne</li>
<li>Rhône-Alpes</li>
</region>
<settlement><li>Barcelone</li>
<li>Lyon</li>
</settlement>
</list>
<tree><country name="Espagne"><region name="Catalogne"><name sortKey="Borras, Josep M" sort="Borras, Josep M" uniqKey="Borras J" first="Josep M" last="Borras">Josep M. Borras</name>
</region>
<name sortKey="Corral, Julieta" sort="Corral, Julieta" uniqKey="Corral J" first="Julieta" last="Corral">Julieta Corral</name>
</country>
<country name="Belgique"><noRegion><name sortKey="Lievens, Yolande" sort="Lievens, Yolande" uniqKey="Lievens Y" first="Yolande" last="Lievens">Yolande Lievens</name>
</noRegion>
</country>
<country name="Australie"><noRegion><name sortKey="Barton, Michael" sort="Barton, Michael" uniqKey="Barton M" first="Michael" last="Barton">Michael Barton</name>
</noRegion>
</country>
<country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Ferlay, Jacques" sort="Ferlay, Jacques" uniqKey="Ferlay J" first="Jacques" last="Ferlay">Jacques Ferlay</name>
</region>
<name sortKey="Bray, Freddie" sort="Bray, Freddie" uniqKey="Bray F" first="Freddie" last="Bray">Freddie Bray</name>
</country>
<country name="Danemark"><noRegion><name sortKey="Grau, Cai" sort="Grau, Cai" uniqKey="Grau C" first="Cai" last="Grau">Cai Grau</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D52 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001D52 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:26922487
   |texte=   How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:26922487" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

Serveur d'exploration sur les relations entre la France et l'Australie

How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.

How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.